Oxford start-up Base Genomics acquired by Exact Sciences
Pharma Times
OCTOBER 28, 2020
Acquisition will enable Base Genomics to accelerate clinical and commercial development
Pharma Times
OCTOBER 28, 2020
Acquisition will enable Base Genomics to accelerate clinical and commercial development
pharmaphorum
OCTOBER 30, 2020
Since entering the pharmaceutical industry as a graduate trainee in the late 1990s, Asad Mohsin Ali’s career has taken him across the business from Novartis, MSD and Tesaro, before joining global biopharma Ipsen. He tells us how the company has responded to COVID and how he’d like to see the UK industry grow in the future. As managing director, Ipsen UK & Ireland, Ali heads up one of Ipsen’s three global hubs, as well as chairing a UK & Ireland Site Steering Committee overseeing 900 peop
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Outsourcing Pharma
OCTOBER 30, 2020
In order to effectively handle collection and analysis of huge volumes of vital data, a leader from IQVIA advises bringing on people up to the challenge.
Pharma Marketing Network
OCTOBER 26, 2020
The pharmaceutical industry deals with copious amounts of personal data, which means that adequate data protection and cybersecurity are non-negotiable. Even two years after the introduction of the General Data Protection Regulation (GDPR), the Information Commissioner Office is still fining companies who fail to fully protect their data. There are two sides of the data protection issue facing the pharma industry.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Pharma Times
OCTOBER 30, 2020
Findings come from new research funded by Cancer Research UK and NIHR
pharmaphorum
OCTOBER 27, 2020
Analysing real-world health data could help overcome the bias towards men in traditional medical research, says Sensyne Health’s Dr Lucy Mackillop. Collecting and analysing anonymised patient data has the potential to generate valuable insights that can catalyse research, lead to improved patient care, and power the development of new treatments.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
NY Times
OCTOBER 29, 2020
Gilead Sciences said Wednesday that remdesivir, which has been authorized for emergency use since the spring, brought in $873 million in revenues so far this year.
Pharma Times
OCTOBER 26, 2020
Trial will investigate chemotherapy drug to alleviate hallucinations in people with Parkinson’s
pharmaphorum
OCTOBER 27, 2020
Eli Lilly says no more patients will be treated with its COVID-19 therapy bamlanivimab in a trial run by the US National Institute of Allergy and Infectious Diseases (NIAID), as results to date suggest it is unlikely to be effective. The ACTIV-3 study was comparing bamlanivimab (also known as LY-CoV555 or LY3819253) and placebo when added to therapy with Gilead Sciences’ Veklury (remdesivir), which is already approved to treat COVID-19 requiring hospitalisation.
Outsourcing Pharma
OCTOBER 26, 2020
The agency has approved the antiviral drug Veklury (remdesivir), produced by Gilead, for hospitalized patients 12 years and over diagnosed with the virus.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Patent Watch
OCTOBER 24, 2020
This chart shows the pharmaceutical companies with the most patents in Sweden. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Sweden? appeared first on DrugPatentWatch - Make Better Decisions.
Pharma Times
OCTOBER 30, 2020
The UK BIA Antibody Taskforce is set to take combinations into further development as a cocktail
pharmaphorum
OCTOBER 28, 2020
The US government said it will buy 300,000 doses of Eli Lilly’s COVID-19 therapy bamlanivimab for $375 million if the drug gets Emergency Use Authorisation (EUA) – although its effectiveness has been called into question. The initial agreement is for delivery over the two months following an EUA, and provides the option for the government to purchase up to an additional 650,000 vials through 30 June 2021.
Outsourcing Pharma
OCTOBER 30, 2020
During the CRAACO conference, a leader from the study solutions firm will discuss how researchers can learn and benefit from the other industry.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
NY Times
OCTOBER 29, 2020
Does a pharmaceutical company have a moral obligation to acknowledge my participation with an ongoing supply of the product that I helped test?
Pharma Times
OCTOBER 28, 2020
Process can help to reduce the time to authorisation of the vaccine
pharmaphorum
OCTOBER 27, 2020
Russia’s sovereign wealth fund has filed applications with the World Health Organization (WHO) that if approved could see the Sputnik V coronavirus vaccine backed for use in many countries around the world. The applications are for two WHO mechanisms, aimed at providing a route to market for vaccines, drugs and other healthcare products that answer public health needs, particularly in low- and middle-income countries.
Outsourcing Pharma
OCTOBER 30, 2020
This year the conference brings its content, focused on the intersection of clinical research and patient care, from the real world to the virtual one.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Patent Watch
OCTOBER 24, 2020
Annual Drug Patent Expirations for TYZEKA Tyzeka is a drug marketed by Novartis and is included in two NDAs. There are three patents protecting this drug. This drug has fifty-five…. The post New patent expiration for Novartis drug TYZEKA appeared first on DrugPatentWatch - Make Better Decisions.
Pharma Times
OCTOBER 28, 2020
Agreement will see vaccine developers make available 200 million doses
pharmaphorum
OCTOBER 29, 2020
With exclusive data from Freedom of Information (FOI) requests sent to the National Institute for Health and are Excellence (NICE), Leela Barham takes a look at the trend in early engagement with the UK’s HTA body. In 2009, NICE was one of the first health technology assessment (HTA) agencies to offer the opportunity for early scientific advice, at a cost.
Outsourcing Pharma
OCTOBER 27, 2020
The clinical research solutions firm is joining forces with pharma giant Eli Lilly to manage mobile research of the monoclonal antibody LY-CoV555.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Drug Patent Watch
OCTOBER 25, 2020
Annual Drug Patent Expirations for CIALIS Cialis is a drug marketed by Lilly and is included in one NDA. It is available from seven suppliers. There is one patent protecting…. The post New patent expiration for LILLY drug CIALIS appeared first on DrugPatentWatch - Make Better Decisions.
Pharma Times
OCTOBER 30, 2020
Drug significantly eliminated oral corticosteroid (OCS) in OCS-dependent asthma patients
pharmaphorum
OCTOBER 27, 2020
Novartis’ pharmaceutical sales recovered in the third quarter of this year after an earlier COVID-19 decline, as new drugs like gene therapy Zolgensma gathered pace. . Correcting for currency fluctuations, net sales were flat at $12.3 billion for the quarter, but reduced spending allowed operating profit to climb 9% compared to the same period of 2019, coming in at $2.4 billion.
Outsourcing Pharma
OCTOBER 29, 2020
A leader from the STA Pharmaceutical subsidiary of WuXI AppTec talks about the dynamic HPAPI market and whatâs ahead for their operation.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Drug Patent Watch
OCTOBER 30, 2020
Annual Drug Patent Expirations for ELLA Ella is a drug marketed by Lab Hra Pharma and is included in one NDA. It is available from one supplier. There are seven…. The post New patent for Lab Hra drug ELLA appeared first on DrugPatentWatch - Make Better Decisions.
Pharma Times
OCTOBER 27, 2020
Investigational oral treatment is being investigated in C3 glomerulopathy
pharmaphorum
OCTOBER 27, 2020
US biotech BioSig Technologies has abandoned a phase 2 trial of its antiviral drug merimepodib with Gilead’s Veklury in severe COVID-19 patients, after concluding the safety of the combination was in doubt. Shares in the company plunged more than 40% on the Nasdaq after the announcement, which revealed a difference in survival rates between the two groups enrolled into the study.
Outsourcing Pharma
OCTOBER 27, 2020
The two companies are working together to develop AT-527, an orally administered, direct-acting antiviral therapy for patients diagnosed with COVID-19.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Let's personalize your content